Incidence and impact on prognosis of heart failure in Middle Eastern patients undergoing percutaneous coronary interventions

by Ayman J Hammoudeh
Published 2017-03-01

Prevalence, Epidemiological Characteristics, and Pharmacotherapy of Coronary Artery Disease among Patients with Atrial Fibrillation: Data from Jo-Fib Study

by Hanna K. Al-Makhamreh, Mohammed Q. Al-Sabbagh, Ala’ E. Shaban, Abdelrahman F. Obiedat, Ayman J. Hammoudeh
Published 2021-06-01

Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The...

by Ayman J. Hammoudeh, Yousef Khader, Nazih Kadri, Eyas Al-Mousa, Yahya Badaineh, Laith Habahbeh, Ramzi Tabbalat, Hesham Janabi, Imad A. Alhaddad
Published 2021-01-01

Cardiovascular risk factors in Middle Eastern patients undergoing percutaneous coronary intervention: Results from the first Jordanian percutaneous coronary intervention study

by Ayman J. Hammoudeh, Imad A. Alhaddad, Yousef Khader, Ramzi Tabbalat, Eyas Al-Mousa, Akram Saleh, Mohamad Jarrah, Assem Nammas, Mahmoud Izraiq
Published 2017-07-01